Phase III Randomized Trial of FOLFIRI Versus FOLFOX4 in the Treatment of Advanced Colorectal Cancer: A Multicenter Study of the Gruppo Oncologico Dell’Italia Meridionale

Journal of Clinical Oncology - United States
doi 10.1200/jco.2005.07.113
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2018English

Safety and Efficacy of Docetaxel Plus Cisplatin Versus Cisplatin Concurrent With Radiation in Local Advanced Cervical Cancer: Midterm Results of a Phase III, Multicenter and Randomized Trial

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Doxorubicin and 5-Fluorouracil Versus Doxorubicin and Oral Ftorafur in the Treatment of Advanced Gastric Cancer—a Phase II and III Trial

Acta Oncologica
Nuclear MedicineRadiologyHematologyOncologyMedicineImaging
1990English

Interim Analysis of Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin Versus Capecitabine Alone for Pathological Stage II and III Rectal Cancer: A Randomized Multicenter Phase III Trial

Oncotarget
Oncology
2016English

a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Study of Simtuzumab in Combination With FOLFIRI for the Second‐Line Treatment of Metastatic KRAS Mutant Colorectal Adenocarcinoma

Oncologist
Cancer ResearchMedicineOncology
2017English

A Randomised, Double-Blind, Placebo-Controlled Multi-Centre Phase III Trial of XELIRI/FOLFIRI Plus Simvastatin for Patients With Metastatic Colorectal Cancer

British Journal of Cancer
Cancer ResearchOncology
2015English

Carboplatin Versus Alternating Carboplatin and Doxorubicin for the Adjuvant Treatment of Canine Appendicular Osteosarcoma: A Randomized, Phase III Trial

Veterinary and Comparative Oncology
Veterinary
2013English

A Trial Protocol of Biweekly TAS-102 and Bevacizumab as Third-Line Chemotherapy for Advanced/Recurrent Colorectal Cancer: A Phase II Multicenter Clinical Trial (The TAS-CC4 Study)

Journal of the Anus, Rectum and Colon
2019English

Phase II Trial of UFT in Advanced Colorectal and Gastric Cancer

British Journal of Cancer
Cancer ResearchOncology
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy